je.st
news
Sanofi, Regeneron drug cuts cholesterol in nine late-stage trials
2014-07-30 16:33:34| Biotech - Topix.net
A new drug being developed by French drugmaker Sanofi and U.S. partner Regeneron cut "bad" LDL cholesterol more than placebo and existing treatments in nine late-stage clinical trials, the companies said on Wednesday.
Tags: drug
cuts
trials
cholesterol
Category:Biotechnology and Pharmaceuticals